Investment Rating - The report assigns a "Buy-A" investment rating to the company, with a 12-month target price of 53.29 CNY [6]. Core Views - The company has shown a strong revenue recovery, achieving 201 million CNY in revenue for H1 2025, a year-on-year increase of 180.16%. The net profit attributable to shareholders reached 57 million CNY, compared to a loss of 24 million CNY in the same period last year [1]. - The company is experiencing a rapid recovery in downstream demand, with significant increases in projects and orders. The gross margin for H1 2025 was 68.04%, up 13.35 percentage points year-on-year, and the net margin was 28.15%, compared to -33.81% in the same period last year [1]. - The company is focusing on R&D, with a 45% increase in R&D expenditure to 53 million CNY in H1 2025, aligning with trends in miniaturization, lightweight, high integration, and low-cost equipment [2]. Financial Summary - The company is projected to achieve net profits of 115 million CNY, 171 million CNY, and 232 million CNY for the years 2025, 2026, and 2027, respectively, with growth rates of 48.3% and 36.2% in the following years [3]. - The company’s revenue is expected to grow from 426 million CNY in 2025 to 737 million CNY in 2027, reflecting a compound annual growth rate (CAGR) of 29.2% [9]. - The company’s accounts receivable increased by 25% to 615 million CNY, primarily due to the growth in business scale [2].
*ST铖昌(001270):需求强劲复苏,加大研发延续先发优势